GHRL and depressive symptom measurement: The discovery of ghrelin in 1999 was followed by an explotion of research to determine the biological role of this peptide and its potential for the treatment of metabolic disorders as well as disorders associated with altered emotional, cognitive and motivational states like depression, anxiety and addiction.